Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma

Osteosarcoma is the most common primary malignant bone tumor with a high metastatic potential. Nowadays, there is a lack of new markers to identify prognosis of osteosarcoma patients with response to medical treatment. Recent studies have shown that hematological markers can reflect to some extent t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Longqing, Wang, Yang, He, Xuanhong, Li, Zhuangzhuang, Lu, Minxun, Gong, Taojun, Chang, Qing, Lin, Jingqi, Liu, Chuang, Luo, Yi, Min, Li, Zhou, Yong, Tu, Chongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120642/
https://www.ncbi.nlm.nih.gov/pubmed/35603156
http://dx.doi.org/10.3389/fimmu.2022.879560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120642/
https://www.ncbi.nlm.nih.gov/pubmed/35603156
http://dx.doi.org/10.3389/fimmu.2022.879560

Ejemplares similares